On-X® Heart Valve Study Results Presented at the Society for Heart Valve Disease 7th Biennial Congress

Published: Jun 25, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

On-X® Life Technologies, Inc. (On-X LTI) announced today that two new PROACT abstracts further demonstrating the safety of maintaining On-X® Prosthetic Heart Valve patients on anticoagulation therapy below currently recommended guidelines are being presented at the Society for Heart Valve Disease 7th Biennial Congress in Venice, Italy, being held June 22-25, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news